Previous Page  1372-1373 / 3107 Next Page
Information
Show Menu
Previous Page 1372-1373 / 3107 Next Page
Page Background

Oligometastases

n=39

Retrospective analysis of radically

treated patients with oligometastatic

NSCLC (n=75)

52

Prospective single-arm phase II trial;

Stage IV NSCLC synchronous M+ < 5

De Ruysscher JTO 2012

Fleckenstein BMC Ca 2016